One gene, SLC2A1, is present in five tumor entities (renal, urothelial, lung, liver and pancreatic cancer) and PLS3, SLC16a1, and SLC16A3 are present in four tumor entities (Table 4). The gene discussed is SLC16A1; the disease is familial pancreatic carcinoma.